An Evaluation of Patient Reported Outcomes and Clinical Outcomes

Description

This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes

Conditions

Post-Operative Complications in Cardiac Surgery

Talk to us

Study Overview

On this page

Study Details

Study overview

This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes

Clinical Protocol REN-007E - Extension Study: An Evaluation of Patient Reported Outcomes and Clinical Outcomes Through 12 Months Post-Cardiac Surgery in Subjects Enrolled in Study REN-007

An Evaluation of Patient Reported Outcomes and Clinical Outcomes

Condition
Post-Operative Complications in Cardiac Surgery
Intervention / Treatment

-

Contacts and Locations

Huntsville

Research Site, Huntsville, Alabama, United States, 35801

Stanford

Research Site, Stanford, California, United States, 94305

Washington

Research Site, Washington, District of Columbia, United States, 20010

Atlantis

Research Site, Atlantis, Florida, United States, 33462

Gainesville

Research Site, Gainesville, Florida, United States, 32608

Atlanta

Research Site, Atlanta, Georgia, United States, 30342

Fort Wayne

Research Site, Fort Wayne, Indiana, United States, 46804

Indianapolis

Research Site, Indianapolis, Indiana, United States, 46202

Indianapolis

Research Site, Indianapolis, Indiana, United States, 46237

Kansas City

Research Site, Kansas City, Kansas, United States, 66160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subjects must have completed the REN-007 study to be eligible to participate in the Extension Study.
  • * Subjects who did not complete the REN-007 study are not eligible to participate in the Extension Study.
  • * Female subjects who become pregnant during the REN-007 study are not eligible to participate in the Extension Study.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Renibus Therapeutics, Inc.,

Study Record Dates

2026-06-30